Jim Cramer Wants Novo Nordisk A/S (NYSE:NVO) To Compete With Eli Lilly In The Market & Not The Courts

This is a summary. Read the complete story at Yahoo Finance below.

Related Stories

marketsabout 6 hours ago

The 2029 tipping point: Western populations are about to start shrinking, piling pressure on public finances

Moody's predicts that the world's aging populations will have fundamental impacts on the global economy and lead to difficult policy decisions.

CNBC Markets

marketsabout 21 hours ago

Corporate America has never been this upbeat about future profits

As third-quarter earnings kick off this week, more companies than ever have expressed optimism about their bottom lines.

MarketWatch

marketsabout 22 hours ago

October can be a scary month for stocks. Here’s what investors need to watch this year.

If stocks see another big swoon this year, investors already know why.

MarketWatch